Literature DB >> 25705470

Crystal structure of di-chlorido-{4-[(E)-(meth-oxy-imino-κN)meth-yl]-1,3-thia-zol-2-amine-κN (3)}palladium(II).

Viktorita V Dyakonenko1, Olga O Zholob2, Svitlana I Orysyk2, Vasily I Pekhnyo2.   

Abstract

In the title compound, [PdCl2(C5n class="CellLine">H7N3OS)], the Pd(II) atom adopts a distorted square-planar coordination sphere defined by two N atoms of the bidentate ligand and two Cl atoms. The mean deviation from the coordination plane is 0.029 Å. The methyl group is not coplanar with the plane of the metallacycle [torsion angle C-O-N-C = 20.2 (4)°]. Steric repulsion between the methyl group and atoms of the metallacycle is manifested by shortened intra-molecular H⋯C contacts of 2.27, 2.38 and 2.64 Å, as compared with the sum of the van der Waals radii of 2.87 Å. The amino group participates via one H atom in the formation of an intra-molecular N-H⋯Cl hydrogen bond. In the crystal, the other H atom of the amino group links mol-ecules via bifurcated N-H⋯(Cl,O) hydrogen bonds into chains parallel to [001].

Entities:  

Keywords:  4-[(meth­oxy­imino)­meth­yl]-1,3-thia­zol-2-amine (MIMTA); crystal structure; multi-functional ligand; palladium

Year:  2015        PMID: 25705470      PMCID: PMC4331851          DOI: 10.1107/S2056989014026619

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Related literature

4-[(Meth­oxy­imino)­meth­yl]-1,3-thia­zol-2-amine (MIMTA) belongs to the class of polyfunctional n class="Chemical">oximes that are potential biologically active complexing agents (Dodoff et al., 2009 ▸; Elo, 2004 ▸; Scaffidi-Domianello et al., 2011 ▸; Donde & Patil, 2011 ▸; Kuwar et al., 2006 ▸). Palladium complexes based on MIMTA are thus inter­esting in biomedicine (Orysyk et al., 2013 ▸). For the structures of related complexes, see: Orysyk et al. (2015 ▸); Mokhir et al. (2002 ▸). For van der Waals radii, see: Zefirov (1997 ▸).

Experimental

Crystal data

[PdCl2(C5n class="CellLine">H7N3OS)] M = 334.50 Orthorhombic, a = 4.347 (3) Å b = 13.583 (2) Å c = 16.411 (3) Å V = 969.0 (7) Å3 Z = 4 Mo Kα radiation μ = 2.64 mm−1 T = 294 K 0.4 × 0.3 × 0.2 mm

Data collection

Agilent Xcalibur Sapphire3 diffractometer Absorption correction: multi-scan (CrysAlis RED; Agilent, 2012 ▸) T min = 0.742, T max = 1.000 4284 measured reflections 2106 independent reflections 2028 reflections with I > 2σ(I) R int = 0.019

Refinement

R[F 2 > 2σ(F 2)] = 0.022 wR(F 2) = 0.047 S = 1.04 2106 reflections 120 parameters H-atom parameters constrained Δρmax = 0.37 e Å−3 Δρmin = −0.36 e Å−3 Absolute structure: Flack (1983), 969 Friedel pairs Absolute structure parameter: 0.39 (4)

Data collection: CrysAlis CCD (Agilent, 2012 ▸); cell refinement: CrysAlis CCD; data reduction: CrysAlis n class="Disease">RED (Agilent, 2012 ▸); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▸); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▸); molecular graphics: OLEX2 (Dolomanov et al., 2009 ▸); software used to prepare material for publication: OLEX2. Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989014026619/wm5096sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989014026619/wm5096Isup2.hkl Click here for additional data file. . DOI: 10.1107/S2056989014026619/wm5096fig1.tif The mol­ecular structure of the title compound. Displacement ellipsoids are drawn at the 50% probability level. Click here for additional data file. . DOI: 10.1107/S2056989014026619/wm5096fig2.tif Crystal packing of the title compound with hydrogen bonds shown as dashed lines. CCDC reference: 1037339 Additional supporting information: crystallographic information; 3D view; checkCIF report
[PdCl2(C5H7N3OS)]Dx = 2.293 Mg m3
Mr = 334.50Mo Kα radiation, λ = 0.71073 Å
Orthorhombic, P212121Cell parameters from 2494 reflections
a = 4.347 (3) Åθ = 3.8–31.7°
b = 13.583 (2) ŵ = 2.64 mm1
c = 16.411 (3) ÅT = 294 K
V = 969.0 (7) Å3, orange
Z = 40.4 × 0.3 × 0.2 mm
F(000) = 648
Agilent Xcalibur Sapphire3 diffractometer2106 independent reflections
Radiation source: Enhance (Mo) X-ray Source2028 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.019
Detector resolution: 16.1827 pixels mm-1θmax = 27.5°, θmin = 3.0°
ω scansh = −5→5
Absorption correction: multi-scan (CrysAlis RED; Agilent, 2012)k = −17→16
Tmin = 0.742, Tmax = 1.000l = −21→21
4284 measured reflections
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.022H-atom parameters constrained
wR(F2) = 0.047w = 1/[σ2(Fo2) + (0.0225P)2 + 0.1807P] where P = (Fo2 + 2Fc2)/3
S = 1.04(Δ/σ)max = 0.002
2106 reflectionsΔρmax = 0.37 e Å3
120 parametersΔρmin = −0.36 e Å3
0 restraintsAbsolute structure: Flack (1983), 969 Friedel pairs
Primary atom site location: structure-invariant direct methodsAbsolute structure parameter: 0.39 (4)
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Pd10.15497 (6)0.986930 (16)0.742144 (12)0.02751 (7)
Cl1−0.1238 (2)1.04846 (7)0.84901 (5)0.0396 (2)
Cl2−0.0192 (2)1.11559 (6)0.66418 (5)0.0411 (2)
S10.6968 (2)0.84020 (7)0.53414 (5)0.0394 (2)
O10.2794 (6)0.86291 (19)0.88793 (12)0.0379 (6)
N10.3271 (7)0.87185 (19)0.80514 (14)0.0306 (6)
N20.3996 (6)0.91712 (19)0.65287 (15)0.0291 (6)
N30.3636 (8)1.0058 (2)0.53113 (15)0.0489 (8)
H3A0.24661.04980.55260.059*
H3B0.41531.01040.48070.059*
C10.5024 (9)0.8046 (3)0.92925 (18)0.0389 (8)
H1A0.47980.81320.98700.058*
H1B0.70500.82490.91300.058*
H1C0.47290.73660.91560.058*
C20.4954 (8)0.8100 (2)0.76650 (18)0.0328 (7)
H20.58190.75520.79160.039*
C30.5408 (8)0.8314 (2)0.68133 (18)0.0315 (7)
C40.7074 (9)0.7815 (3)0.62715 (19)0.0375 (8)
H40.81380.72360.63790.045*
C50.4632 (8)0.9318 (2)0.57529 (18)0.0317 (7)
U11U22U33U12U13U23
Pd10.03240 (12)0.02459 (11)0.02555 (10)−0.00010 (10)−0.00195 (9)0.00015 (8)
Cl10.0450 (5)0.0412 (5)0.0327 (4)0.0059 (4)0.0021 (4)−0.0055 (3)
Cl20.0511 (5)0.0326 (4)0.0394 (4)0.0092 (4)−0.0021 (4)0.0062 (4)
S10.0506 (6)0.0390 (5)0.0286 (4)0.0037 (5)0.0042 (4)−0.0028 (3)
O10.0456 (14)0.0444 (14)0.0237 (9)0.0096 (12)0.0026 (10)0.0059 (9)
N10.0373 (15)0.0304 (14)0.0240 (11)−0.0015 (15)−0.0013 (12)0.0048 (10)
N20.0361 (16)0.0239 (13)0.0273 (12)−0.0007 (12)−0.0025 (11)0.0012 (10)
N30.077 (2)0.0424 (17)0.0276 (12)0.014 (2)0.0087 (14)0.0054 (12)
C10.045 (2)0.045 (2)0.0260 (14)0.006 (2)−0.0007 (16)0.0053 (14)
C20.0409 (18)0.0273 (15)0.0303 (15)0.0048 (15)−0.0018 (15)0.0024 (13)
C30.0388 (18)0.0277 (17)0.0282 (14)−0.0013 (15)−0.0032 (14)−0.0001 (13)
C40.045 (2)0.0342 (18)0.0333 (15)0.0069 (17)−0.0021 (16)−0.0014 (13)
C50.0385 (18)0.0316 (18)0.0251 (14)−0.0029 (16)0.0012 (14)0.0012 (13)
Pd1—Cl12.2897 (10)N3—H3A0.8600
Pd1—Cl22.2943 (9)N3—H3B0.8600
Pd1—N12.018 (3)N3—C51.313 (4)
Pd1—N22.044 (3)C1—H1A0.9600
S1—C41.723 (3)C1—H1B0.9600
S1—C51.742 (3)C1—H1C0.9600
O1—N11.380 (3)C2—H20.9300
O1—C11.423 (4)C2—C31.441 (4)
N1—C21.282 (4)C3—C41.332 (5)
N2—C31.397 (4)C4—H40.9300
N2—C51.318 (4)
Cl1—Pd1—Cl288.54 (4)O1—C1—H1B109.5
N1—Pd1—Cl194.96 (8)O1—C1—H1C109.5
N1—Pd1—Cl2176.43 (8)H1A—C1—H1B109.5
N1—Pd1—N279.34 (10)H1A—C1—H1C109.5
N2—Pd1—Cl1173.65 (8)H1B—C1—H1C109.5
N2—Pd1—Cl297.20 (8)N1—C2—H2122.4
C4—S1—C590.16 (16)N1—C2—C3115.2 (3)
N1—O1—C1114.6 (2)C3—C2—H2122.4
O1—N1—Pd1121.1 (2)N2—C3—C2115.6 (3)
C2—N1—Pd1117.8 (2)C4—C3—N2116.1 (3)
C2—N1—O1121.0 (3)C4—C3—C2128.3 (3)
C3—N2—Pd1112.1 (2)S1—C4—H4125.0
C5—N2—Pd1137.0 (2)C3—C4—S1110.0 (3)
C5—N2—C3110.9 (3)C3—C4—H4125.0
H3A—N3—H3B120.0N2—C5—S1112.9 (2)
C5—N3—H3A120.0N3—C5—S1121.7 (2)
C5—N3—H3B120.0N3—C5—N2125.4 (3)
O1—C1—H1A109.5
Pd1—N1—C2—C30.1 (4)N1—C2—C3—N20.9 (5)
Pd1—N2—C3—C2−1.4 (4)N1—C2—C3—C4178.7 (4)
Pd1—N2—C3—C4−179.5 (3)N2—Pd1—N1—O1175.8 (3)
Pd1—N2—C5—S1179.58 (19)N2—Pd1—N1—C2−0.7 (3)
Pd1—N2—C5—N3−1.1 (6)N2—C3—C4—S1−0.2 (4)
Cl1—Pd1—N1—O1−7.0 (2)C1—O1—N1—Pd1−156.2 (2)
Cl1—Pd1—N1—C2176.4 (3)C1—O1—N1—C220.2 (4)
Cl1—Pd1—N2—C3−25.3 (9)C2—C3—C4—S1−178.0 (3)
Cl1—Pd1—N2—C5155.6 (5)C3—N2—C5—S10.5 (4)
Cl2—Pd1—N1—O1161.6 (12)C3—N2—C5—N3179.8 (3)
Cl2—Pd1—N1—C2−14.9 (15)C4—S1—C5—N2−0.5 (3)
Cl2—Pd1—N2—C3−179.7 (2)C4—S1—C5—N3−179.8 (3)
Cl2—Pd1—N2—C51.2 (3)C5—S1—C4—C30.4 (3)
O1—N1—C2—C3−176.4 (3)C5—N2—C3—C2177.9 (3)
N1—Pd1—N2—C31.1 (2)C5—N2—C3—C4−0.2 (4)
N1—Pd1—N2—C5−178.0 (4)
D—H···AD—HH···AD···AD—H···A
N3—H3A···Cl20.862.343.124 (3)151
N3—H3B···Cl1i0.862.483.280 (3)156
N3—H3B···O1i0.862.453.015 (3)124
Table 1

Hydrogen-bond geometry (, )

DHA DHHA D A DHA
N3H3ACl20.862.343.124(3)151
N3H3BCl1i 0.862.483.280(3)156
N3H3BO1i 0.862.453.015(3)124

Symmetry code: (i) .

  3 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Uniform potent activity of the antiproliferative metal chelate trans-bis(resorcylaldoximato)copper(II) against a large panel of human tumor cell lines in vitro.

Authors:  Hannu Elo
Journal:  Chemotherapy       Date:  2004-11-03       Impact factor: 2.544

3.  Synthesis, characterization, and cytotoxic activity of novel potentially pH-sensitive nonclassical platinum(II) complexes featuring 1,3-dihydroxyacetone oxime ligands.

Authors:  Yulia Yu Scaffidi-Domianello; Anton A Legin; Michael A Jakupec; Vladimir B Arion; Vadim Yu Kukushkin; Mathea Sophia Galanski; Bernhard K Keppler
Journal:  Inorg Chem       Date:  2011-09-27       Impact factor: 5.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.